Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice

被引:30
作者
Jayasekera, Jerome P.
Vinuesa, Carola G.
Karupiah, Gunasegaran
King, Nicholas J. C.
机构
[1] Univ Sydney, Dept Pathol, Bosch Inst, Sch Biomed Sci, Sydney, NSW 2006, Australia
[2] Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia
关键词
D O I
10.1099/vir.0.82131-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
NOS2 gene-deficient (NOS2(-/-)) mice are less susceptible than wild-type (NOS2(+/+)) mice to infection with Influenza A virus. Virus titres in the lungs of influenza-infected NOS2(-/-) mice are significantly lower than those in NOS2(+/+) mice, with enhanced viral clearance in NOS2(-1-) mice dependent on gamma interferon (IFN-gamma). The current study was undertaken to ascertain the role of specific components of the immune response in promoting virus clearance in influenza-infected NOS2(-/-) mice. Levels of T cell- and natural killer cell-mediated cytotoxicity in the lungs of virus-infected mice were not significantly different between NOS2(+/+) and NOS2(-/-) mice. However, virus-infected NOS2-1- mice produced higher levels of virus-specific IgG2a antibody. Furthermore, more viable B cells and plasmablasts, along with greater levels of IFN-gamma were found in NOS2(-/-) splenocyte cultures stimulated with B-cell mitogens. In addition to the early reduction in virus titres, clinical symptoms and proinflammatory cytokine production were attenuated in NOS2(-/-) mice. Thus, NOS2(-/-) B cells are capable of responding rapidly to influenza virus infection by proliferating and preferentially producing antibody of the IgG2a subtype. The relationship between viral load and the development of immunopathology is discussed.
引用
收藏
页码:3361 / 3371
页数:11
相关论文
共 57 条
[1]   Suppression of Herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2) [J].
Adler, H ;
Beland, JL ;
DelPan, NC ;
Kobzik, L ;
Brewer, JP ;
Martin, TR ;
Rimm, IJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) :1533-1540
[2]   8-Nitroguanosine formation in viral pneumonia and its implication for pathogenesis [J].
Akaike, T ;
Okamoto, S ;
Sawa, T ;
Yoshitake, J ;
Tamura, F ;
Ichimori, K ;
Miyazaki, K ;
Sasamoto, K ;
Maeda, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (02) :685-690
[3]   Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals [J].
Akaike, T ;
Noguchi, Y ;
Ijiri, S ;
Setoguchi, K ;
Suga, M ;
Zheng, YM ;
Dietzschold, B ;
Maeda, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2448-2453
[4]   The influence of virus structure on antibody responses and virus serotype formation [J].
Bachmann, MF ;
Zinkernagel, RM .
IMMUNOLOGY TODAY, 1996, 17 (12) :553-558
[5]   Blood dendritic cells interact with splenic marginal zone B cells to initiate T-Independent immune responses [J].
Balázs, M ;
Martin, F ;
Zhou, T ;
Kearney, JF .
IMMUNITY, 2002, 17 (03) :341-352
[6]   BAFF mediates survival of peripheral immature B lymphocytes [J].
Batten, M ;
Groom, J ;
Cachero, TG ;
Qian, F ;
Schneider, P ;
Tschopp, J ;
Browning, JL ;
Mackay, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) :1453-1465
[7]   In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the focal cellular immune response in lung tissue [J].
Baumgarth, N ;
Kelso, A .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4411-4418
[8]  
BEEBE DP, 1983, J IMMUNOL, V130, P1317
[9]   TRANSGENIC MICE LACKING CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED T-CELLS HAVE DELAYED VIRAL CLEARANCE AND INCREASED MORTALITY AFTER INFLUENZA-VIRUS CHALLENGE [J].
BENDER, BS ;
CROGHAN, T ;
ZHANG, LP ;
SMALL, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :1143-1145
[10]   Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection [J].
Cerwenka, A ;
Morgan, TM ;
Harmsen, AG ;
Dutton, RW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :423-434